Sarepta Therapeutics: Q4 Earnings Insights

Sarepta Therapeutics SRPT reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Sarepta Therapeutics beat estimated earnings by 31.86%, reporting an EPS of $-0.77 versus an estimate of $-1.13.

Revenue was up $56.32 million from the same period last year.

Last quarter the company beat on EPS by $1.7 which was followed by a 0.51% increase in the share price the next day.

Here's a look at Sarepta Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-1.89	-1.29	-1.78	-1.77
EPS Actual	-0.19	-1.52	-1.54	-1.84
Revenue Estimate	173.42M	162.64M	143.33M	146.29M
Revenue Actual	189.41M	164.09M	146.93M	145.14M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar